We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VBIVQ market cap is 456.05k. The company's latest EPS is USD -3.2717 and P/E is -0.02.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.22M | 1.06M | 631k | 1.08M | 8.68M |
| Operating Income | -46.11M | -43.62M | -68.03M | -81.82M | -55.31M |
| Net Income | -54.81M | -46.23M | -69.75M | -113.3M | -93.84M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 122.2M | 209.37M | 210.28M | 155.09M | 86.95M |
| Total Liabilities | 33.95M | 37.67M | 66.39M | 90.92M | 79.42M |
| Total Equity | 88.26M | 171.71M | 143.88M | 64.16M | 7.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -48.71M | -47.05M | -39.91M | -73.7M | -60.88M |
| Investing | -3.67M | -26M | 23.16M | -4.34M | -867k |
| Financing | 37.42M | 122.39M | 44.29M | 19.45M | 22.7M |
| Market Cap | 456.05k |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0.23 |
| Price to Cash Ratio | 0.08 |
| Price to Book Ratio | 0.27 |
| Dividend Yield | - |
| Shares Outstanding | 28.68M |
| Average Volume (1 week) | 438.67k |
| Average Volume (1 Month) | 213.62k |
| 52 Week Change | -47.00% |
| 52 Week High | 0.0505 |
| 52 Week Low | 0.00485 |
| Spread (Intraday) | 0.01 (40.48%) |
| Company Name | VBI Vaccines Inc (PK) |
| Address |
suite 1700, park place vancouver, british columbia V6C 2X8 |
| Website | https://www.levon.com |
| Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
